Top View
- Metastatic Breast Cancer: Overview for Oncology Clinical Practice
- Indirect AMP-Activated Protein Kinase Activators Prevent Incision-Induced
- Integrative Kinome Profiling Identifies Mtorc1/2 Inhibition As Treatment Strategy in Ovarian Clear Cell Carcinoma
- Dual Targeting of BRAF and Mtor Signaling in Melanoma Cells with Pyridinyl Imidazole Compounds
- Mtor Signaling Pathway and Mtor Inhibitors in Cancer: Progress and Challenges Zhilin Zou1,2,3†, Tao Tao4†, Hongmei Li3* and Xiao Zhu1,2*
- Discovery of Potent and Selective MRCK Inhibitors with Therapeutic
- Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/ PTEN/Akt/Mtor Cascades Which Alter Therapy Response
- PI3K/Akt/Mtor Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer David C
- Hereditary Cancer Panel Descriptions
- The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
- Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation
- Key Signaling Pathways in Aging and Potential Interventions for Healthy Aging
- Characterization of the Endothelial Cell Cytoskeleton Following HLA Class I Ligation
- Dual Inhibition of BRAF and Mtor in BRAFV600E-Mutant Pediatric, Adolescent, and Young Adult Brain Tumors
- Connectivity Map Analysis Indicates PI3K/Akt/Mtor Inhibitors As Potential Anti-Hypoxia Drugs in Neuroblastoma
- Mtor Signaling, Function, Novel Inhibitors, and Therapeutic Targets
- The Mtor Story
- Snapshot: Breast Cancer Kornelia Polyak and Otto Metzger Filho Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215 USA
- Clinical Significance of Mtor, ZEB1, ROCK1 Expression in Lung Tissues
- Signaling Through Cyclin D-Dependent Kinases
- AMPK and Mtor Impose Dualistic Regulation of Mitophagy and Autophagy in in Vitro Models of Prostate Cancer
- Prevalence of Germline Mutations in Cancer Susceptibility Genes In
- The Activators of Cyclin-Dependent Kinase 5 P35 and P39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination
- MAP3K1 and MAP2K4 Mutations Are Associated with Sensitivity to MEK Inhibitors in Multiple Cancer Models
- The Upstream Pathway of Mtor-Mediated Autophagy in Liver Diseases
- Suppl. Table 1. Somatic Single Nucleotide Substitution Spectrum
- Figure S1. the PI3K/AKT/Mtor Pathway Activation Leads to Cell Growth
- A Novel Recurrent CHEK2 Y390C Mutation Identified in High-Risk
- Genome-Wide CRISPR Screen Identifies Regulators of MAPK and MTOR Pathways Mediating Sorafenib Resistance in Acute Myeloid Leukemia
- Exceptional Response to Everolimus in a Novel Tuberous Sclerosis Complex-2 Mutation–Associated Metastatic Renal-Cell Carcinoma
- RT² Profiler PCR Array (96-Well Format and 384-Well [4 X 96] Format)
- Crosstalk Between the Mtor and DNA Damage Response Pathways in Fission Yeast
- A Pathway Linking Translation Stress to Checkpoint Kinase 2 Signaling in Neurospora Crassa
- Normal Myogenesis and Increased Apoptosis in Myotonic Dystrophy Type 1 Muscle Cells
- ATM Protein Kinase: Old and New Implications in Neuronal Pathways and Brain Circuitry
- Genetic Analysis of the PI3K/AKT/Mtor Signaling Pathway Janna Hutz Washington University in St
- Normal Myogenesis and Increased Apoptosis in Myotonic Dystrophy Type-1 Muscle Cells
- Effect of BRAF‑Mediated PI3K/Akt/Mtor Pathway on Biological Characteristics and Chemosensitivity of NSCLC A549/DDP Cells
- Targeted Profiling of RNA Translation Reveals Mtor-4EBP1/2
- PDK1-Mediated Activation of Mrckα Regulates Directional Cell Migration
- Twenty-Five Years of Mtor: Uncovering the Link from Nutrients to Growth
- Mtorc1 Regulates Cytokinesis Through Activation of Rho-ROCK
- Snapshot: Mtor Signaling Alexandre Soulard and Michael N
- Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Suppresses
- Identification of Potential Synthetic Lethal Genes Ot P53 Using a Computational Biology Approach
- Rho Kinase Inhibition As a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration
- ATM Signalling and Cancer
- Sequential Or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6
- SHORT Syndrome Due to a Novel De Novo Mutation in PRKCE (Protein Kinase Cɛ ) Impairing TORC2Dependent AKT Activation
- Pulsed Electromagnetic Fields Increase Osteogenetic Commitment
- CDK1 Substitutes for Mtor Kinase to Activate Mitotic Cap-Dependent
- Pathway-Directed Therapy in Multiple Myeloma
- Products and Services ターゲットリスト
- Mtor Signaling in Kidney Diseases
- Stimulated Protein Synthesis in Rat Skeletal Muscle1,2 Downloaded from by Guest on 27 September 2021 Anne M
- Association of Breast and Ovarian Cancers with Predisposition Genes Identified by Large-Scale Sequencing
- SHORT Syndrome Due to a Novel De Novo Mutation in PRKCE (Protein Kinase C) Impairing TORC2-Dependent AKT Activation